Home › NDC Lookup › RxCUI directory › RxCUI 1099687

Valproic acid 50 MG/ML Oral Solution — RxCUI 1099687

RxNorm drug concept · Semantic clinical drug
RxCUI 1099687 Semantic clinical drug · SCD ● Current RxNorm concept 15 FDA products 24 package NDCs Snapshot Jul 14, 2026

This page is curated, coded, and maintained by

Compiled from public NLM RxNorm and FDA (openFDA NDC directory) data sources. Editorial policy

What you’re looking at: the standardized identity of one medicine, as the U.S. drug-data system sees it. Below — every FDA-listed product, package code, price benchmark, and billing code that maps to it.

🗂️ Key Facts

RxCUI1099687
Official nameValproic acid 50 MG/ML Oral Solution
Concept typeSemantic clinical drug (SCD)
RxNorm statusCurrent RxNorm concept
Also known asVPA 50 MG/ML Oral Solution; valproic acid 250 MG in 5 mL Oral Solution; valproate sodium 50 MG/ML Syrup; valproic acid 250 MG per 5 ML Oral Solution; valproic acid 500 MG per 10 ML Oral Solution
FDA products mapped15
Package NDCs mapped24
Reported Medicaid activity (SDUD)236,874 prescriptions · 52 state & territory Medicaid programs · latest period Q4 2025
RxNorm release07/06/2026
Snapshot dataJul 14, 2026

📖 Skip the Codes — Read It in Plain English.

Our pharmacist-built guide to Divalproex: what it is, how it’s used, side effects, and interactions.

📗 Our plain-language guide HelloPharmacist
  • It treats seizures, manic episodes of bipolar disorder, and prevents migraines. Which uses apply depends on the product. Capsules are only for seizures. Ask me to check which one y...
  • Swallow tablets whole and never crush or chew them. Extended-release tablets are once a day. Capsules can be swallowed whole or sprinkled on soft food and swallowed right away. Tak...
  • For delayed-release tablets, take it as soon as you remember unless it is almost time for the next dose. Do not double up. Ask your prescriber if you take another form.
  • Nausea, stomach upset, sleepiness, dizziness, tremor, headache and hair loss are common. Call your doctor if they bother you a lot. Call right away for severe stomach pain, vomitin...
📖 Read our full Divalproex guide →

🕸️ Concept Web — How Valproic acid 50 MG/ML Oral Solution Connects

One RxCUI never lives alone. Follow the path from the raw ingredient down to the exact strength-and-form concepts FDA products carry — every stop is a real RxNorm concept with its own identifier. Hover or focus any chip for what it means.
This page's concept Valproic acid 50 MG/ML Oral Solution RxCUI 1099687

Every web starts here: one RxCUI, one fixed meaning in the RxNorm vocabulary.

  1. Ingredients 2

    The active substance itself — no strength, form, or brand attached yet.

    • Valproate 40254
    • Valproic acid 11118
  2. Dose forms 9

    The ingredient poured into a form — tablet, solution, cream — still without one fixed strength.

    • Valproate Oral Solution 808657
    • Valproic acid Oral Solution 2647128
    • Valproate Oral Liquid Product 1159995
    • Valproate Oral Product 1159996
    • Valproic acid Oral Liquid Product 2662138
    • Valproic acid Oral Product 2661591
    • Oral Solution 316968
    • Oral Liquid Product 1151137
    • +1 more in this family
  3. Clinical & branded drugs 1

    Ingredient + strength + dose form. These are the concepts real FDA products actually carry.

    • Valproic acid 50 MG/ML 1099685

Showing up to 8 concepts per family — 11 of 12 stored related concepts drawn.
These are official RxNorm vocabulary relationships — how concepts name and organize the same medicine. They do not establish therapeutic equivalence or substitutability: two concepts appearing in one web is never a statement that products can be swapped.

🔀 Generic ⇄ Brand Crosswalk

The same medicine has an unbranded (generic) identity and one or more brand-name identities — each with its own RxCUI. This is a naming relationship in RxNorm, not a statement that any two products are substitutable.

Generic (Clinical) Concepts

  • Valproic acid 50 MG/ML SCDC · 1099685
  • Valproate Oral Solution SCDF · 808657
  • Valproic acid Oral Solution SCDFP · 2647128
  • Valproate Oral Liquid Product SCDG · 1159995
  • Valproate Oral Product SCDG · 1159996
  • Valproic acid Oral Liquid Product SCDGP · 2662138
  • Valproic acid Oral Product SCDGP · 2661591

📦 FDA Products & Package NDCs

15 products · 24 package NDCs
24 package NDCs map to RxCUI 1099687 in the current snapshot — up to 50 per page. Each linked NDC opens its full package page.
Package NDC Package Brand / generic name Labeler Marketing start
00116-4021-11 10 TRAY in 1 CASE (0116-4021-11) / 10 CUP, UNIT-DOSE in 1 T... Valproic Acid Xttrium Laboratories Inc. 2025-07-29
00116-4021-16 473 mL in 1 BOTTLE, PLASTIC (0116-4021-16) Valproic Acid Xttrium Laboratories Inc. 2025-07-29
00116-4021-40 4 TRAY in 1 CASE (0116-4021-40) / 10 CUP, UNIT-DOSE in 1 TR... Valproic Acid Xttrium Laboratories Inc. 2025-07-29
00116-4021-41 10 TRAY in 1 CASE (0116-4021-41) / 10 CUP, UNIT-DOSE in 1 T... Valproic Acid Xttrium Laboratories Inc. 2025-07-29
00121-0675-85 473 mL in 1 BOTTLE (0121-0675-85) VALPROIC ACID PAI Holdings, LLC dba PAI Pharma 2021-08-11
00121-1350-00 10 TRAY in 1 CASE (0121-1350-00) / 10 CUP, UNIT-DOSE in 1 T... VALPROIC ACID PAI Holdings, LLC dba PAI Pharma 2005-04-11
00121-4675-00 10 TRAY in 1 CASE (0121-4675-00) / 10 CUP, UNIT-DOSE in 1 T... VALPROIC ACID PAI Holdings, LLC dba PAI Pharma 2005-04-11
00121-4675-40 4 TRAY in 1 CASE (0121-4675-40) / 10 CUP, UNIT-DOSE in 1 TR... VALPROIC ACID PAI Holdings, LLC dba PAI Pharma 2005-04-11
62135-0196-24 2 TRAY in 1 BOX (62135-196-24) / 10 CUP in 1 TRAY / 5 mL in... Valproic Acid Chartwell RX, LLC 2024-05-28
62135-0196-47 473 mL in 1 BOTTLE (62135-196-47) Valproic Acid Chartwell RX, LLC 2022-08-15
62135-0874-24 2 TRAY in 1 BOX (62135-874-24) / 10 CUP in 1 TRAY / 10 mL i... Valproic Acid Chartwell RX, LLC 2024-05-28
62559-0266-16 473 mL in 1 BOTTLE (62559-266-16) Valproic Acid ANI Pharmaceuticals, Inc. 2024-01-02
68999-0196-24 2 TRAY in 1 BOX (68999-196-24) / 10 CUP in 1 TRAY / 5 mL in... Valproic Acid Chartwell Governmental & Specialty RX, LLC. 2025-11-14
68999-0874-24 2 TRAY in 1 BOX (68999-874-24) / 10 CUP in 1 TRAY / 10 mL i... Valproic Acid Chartwell Governmental & Specialty RX, LLC. 2025-11-14
70518-3805-00 10 CUP, UNIT-DOSE in 1 BOX (70518-3805-0) / 5 mL in 1 CUP,... VALPROIC ACID REMEDYREPACK INC. 2023-07-25
70518-3805-02 10 CUP, UNIT-DOSE in 1 BOX (70518-3805-2) / 10 mL in 1 CUP,... VALPROIC ACID REMEDYREPACK INC. 2024-03-13
70518-4298-00 10 CUP in 1 BOX (70518-4298-0) / 20 mL in 1 CUP (70518-4298... Valproic Acid REMEDYREPACK INC. 2025-02-27
70518-4298-02 10 CUP in 1 BOX (70518-4298-2) / 10 mL in 1 CUP (70518-4298... Valproic Acid REMEDYREPACK INC. 2025-02-27
70518-4298-04 10 CUP in 1 BOX (70518-4298-4) / 5 mL in 1 CUP (70518-4298-... Valproic Acid REMEDYREPACK INC. 2025-02-27
70752-0202-12 12 BOTTLE in 1 CASE (70752-202-12) / 473 mL in 1 BOTTLE VALPROIC ACID QUAGEN PHARMACEUTICALS LLC 2024-04-15
71335-2250-01 473 mL in 1 BOTTLE (71335-2250-1) VALPROIC ACID Bryant Ranch Prepack 2021-08-11
72603-0253-01 473 mL in 1 BOTTLE (72603-253-01) Valproic Acid NorthStar Rx LLC 2024-06-10
81033-0266-50 100 CUP, UNIT-DOSE in 1 CASE (81033-266-50) / 5 mL in 1 CUP... Valproic Acid Kesin Pharma Corporation 2025-08-01
81033-0266-52 100 CUP, UNIT-DOSE in 1 CASE (81033-266-52) / 10 mL in 1 CU... Valproic Acid Kesin Pharma Corporation 2025-08-01
Observed labelers: REMEDYREPACK INC. (5) · PAI Holdings, LLC dba PAI Pharma (4) · Xttrium Laboratories Inc. (4) · Chartwell RX, LLC (3) · Chartwell Governmental & Specialty RX, LLC. (2) · Kesin Pharma Corporation (2) · +4 more — this is the FDA-listed mapping footprint, not sales, inventory, availability, or market share.

🗃️ Sources & Limits

Atlas generation902fddb9-e9c1-4004-bf4c-dba4d51037c7
openFDA export observedJul 14, 2026
RxNorm release07/06/2026
Methodology2026-07-full-catalog-v1
  • A shared RxCUI does not prove interchangeability. Products mapped to the same concept are not thereby equivalent or substitutable — equivalence is a separate, product-level determination.
  • Listing here does not establish approval or coverage. Appearing in this snapshot is a data observation, not an FDA approval status or a payer coverage decision.
  • Missing data never means zero. A silent dataset (no price, no billing code, no utilization) means no observation — not that the real-world value is zero.
  • Counts describe the mapping footprint. Product, package, and labeler counts are the FDA-listed mapping footprint in this snapshot — not sales, inventory, availability, or market share.
This product uses publicly available data from the U.S. National Library of Medicine (NLM), National Institutes of Health, Department of Health and Human Services; NLM is not responsible for the product and does not endorse or recommend this or any other product.

Machine-readable JSON

Reference information about drug-concept identifiers and public regulatory data — not medical advice. Talk to your pharmacist or prescriber about your own medication.